Introduction by the moderator - Thomas Albrecht, Berlin / DE
02:00
2
Improved visualisation of hepatic tumours in magnetic resonance guided thermoablation using T1 inversion-recovery imaging compared to T1 volume-interpolated breath-hold sequence - Jens Kuebler, Tübingen / DE
08:00
3
Novel needle-guiding robotic system for percutaneous minimally invasive procedures: a technical feasibility study - Jurgen J. Futterer, Nijmegen / NL
08:00
4
The role of volumetric assessment in predicting the success of percutaneous transhepatic biliary drainage in inoperable Klatskin tumours - Gülsüm Bahadır, ANKARA / TR
08:00
5
Risk of persistent air leaks following percutaneous cryoablation and microwave ablation of peripheral lung tumours: a bi-institutional retrospective study - Florian Fintelmann, Boston / US
08:00
6
US-CT fusion-guided percutaneous radiofrequency ablation of large substernal benign thyroid nodules - Umberto Viglino, Genoa / IT
08:00
7
MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of benign prostatic hyperplasia: early outcomes - Cameron Wright, Hamburg / DE
08:00
8
12-month functional and oncological outcomes of salvage TULSA for localised radio-recurrent prostate cancer - Cameron Wright, Hamburg / DE
08:00
9
Percutaneous tumour ablation guided by electromagnetic navigation system: a retrospective study - Sofía Ventura Díaz, Manzanares el Real / ES
08:00
10
Multi-institutional study on safety and effectiveness of percutaneous RF, MW and cryo-ablation for T1 renal cancers: which is the best imaging guide? - Lorenzo Bertolotti, PARMA / IT